Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trulieve Cannabis Corp C.TRUL

Alternate Symbol(s):  TCNNF | C.TRUL.NT.U

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.


CSE:TRUL - Post by User

Bullboard Posts
Comment by FunGuy88on Jun 25, 2020 9:35am
70 Views
Post# 31189647

RE:RE:Down quite a bit for no real apparent reason

RE:RE:Down quite a bit for no real apparent reasonBlizzy I really don't understand your post at all. How has the growth ended or medical results fallen 26%? The weekly OMMU numbers for April, May, and June so far have been higher than the first Q1 of 2020. And what do you mean by "3 weeks in the books this quarter," the quarter is almost done with one week remaining. Was there a report or guidance that came out that you are referring too, because it does not seem like there is anything supporting your statements.
Bullboard Posts